247 related articles for article (PubMed ID: 12101435)
1. Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle.
Abadie J; Blouin V; Guigand L; Wyers M; Cherel Y
Gene Ther; 2002 Aug; 9(15):1037-43. PubMed ID: 12101435
[TBL] [Abstract][Full Text] [Related]
2. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy.
Li J; Dressman D; Tsao YP; Sakamoto A; Hoffman EP; Xiao X
Gene Ther; 1999 Jan; 6(1):74-82. PubMed ID: 10341878
[TBL] [Abstract][Full Text] [Related]
3. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
[TBL] [Abstract][Full Text] [Related]
4. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
5. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
6. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.
Blankinship MJ; Gregorevic P; Allen JM; Harper SQ; Harper H; Halbert CL; Miller AD; Chamberlain JS
Mol Ther; 2004 Oct; 10(4):671-8. PubMed ID: 15451451
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle.
Favre D; Cherel Y; Provost N; Blouin V; Ferry N; Moullier P; Salvetti A
Gene Ther; 2000 Aug; 7(16):1417-20. PubMed ID: 10981669
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
9. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
Rivière C; Danos O; Douar AM
Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).
Athanasopoulos T; Graham IR; Foster H; Dickson G
Gene Ther; 2004 Oct; 11 Suppl 1():S109-21. PubMed ID: 15454965
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle regeneration after insulin-like growth factor I gene transfer by recombinant Sendai virus vector.
Shiotani A; Fukumura M; Maeda M; Hou X; Inoue M; Kanamori T; Komaba S; Washizawa K; Fujikawa S; Yamamoto T; Kadono C; Watabe K; Fukuda H; Saito K; Sakai Y; Nagai Y; Kanzaki J; Hasegawa M
Gene Ther; 2001 Jul; 8(14):1043-50. PubMed ID: 11526451
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated virus-mediated transfer of human acid maltase gene results in a transient reduction of glycogen accumulation in muscle of Japanese quail with acid maltase deficiency.
Lin CY; Ho CH; Hsieh YH; Kikuchi T
Gene Ther; 2002 May; 9(9):554-63. PubMed ID: 11973631
[TBL] [Abstract][Full Text] [Related]
13. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration.
Bostick B; Ghosh A; Yue Y; Long C; Duan D
Gene Ther; 2007 Nov; 14(22):1605-9. PubMed ID: 17898796
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors.
Chen Y; Luk KD; Cheung KM; Xu R; Lin MC; Lu WW; Leong JC; Kung HF
Gene Ther; 2003 Aug; 10(16):1345-53. PubMed ID: 12883531
[TBL] [Abstract][Full Text] [Related]
15. Receptor targeting of adeno-associated virus vectors.
Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
[TBL] [Abstract][Full Text] [Related]
16. Construction and analysis of compact muscle-specific promoters for AAV vectors.
Wang B; Li J; Fu FH; Chen C; Zhu X; Zhou L; Jiang X; Xiao X
Gene Ther; 2008 Nov; 15(22):1489-99. PubMed ID: 18563184
[TBL] [Abstract][Full Text] [Related]
17. Targeting functional subtypes of spinal motoneurons and skeletal muscle fibers in vivo by intramuscular injection of adenoviral and adeno-associated viral vectors.
Martinov VN; Sefland I; Walaas SI; Lømo T; Njå A; Hoover F
Anat Embryol (Berl); 2002 Jun; 205(3):215-21. PubMed ID: 12107491
[TBL] [Abstract][Full Text] [Related]
18. AAV-directed muscular dystrophy gene therapy.
Tang Y; Cummins J; Huard J; Wang B
Expert Opin Biol Ther; 2010 Mar; 10(3):395-408. PubMed ID: 20132060
[TBL] [Abstract][Full Text] [Related]
19. Efficient gene transfer into human keratinocytes with recombinant adeno-associated virus vectors.
Braun-Falco M; Doenecke A; Smola H; Hallek M
Gene Ther; 1999 Mar; 6(3):432-41. PubMed ID: 10435093
[TBL] [Abstract][Full Text] [Related]
20. Recombinant AAV vectors containing the foot and mouth disease virus 2A sequence confer efficient bicistronic gene expression in cultured cells and rat substantia nigra neurons.
Furler S; Paterna JC; Weibel M; Büeler H
Gene Ther; 2001 Jun; 8(11):864-73. PubMed ID: 11423934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
